Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8+ T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome

Acta Neuropathologica

Volumn 129, Issue 3, 2015, Pages 463-465

  Martin Blondel, Guillaume ^a,b,c   Bauer, Jan ^d   Uro Coste, Emmanuelle ^a,c,e   Biotti, Damien ^a   Averseng Peaureaux, Delphine ^a,c   Fabre, Nelly ^a   Dumas, Hervé ^a   Bonneville, Fabrice ^a,c   Lassmann, Hans ^d   Marchou, Bruno ^a,c   Liblau, Roland S ^b,c   Brassat, David ^a,b,c  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b France   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d Medical University of Vienna   (Austria)

^e CANCER RESEARCH CENTER OF TOULOUSE   (France)

^f CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR5; MARAVIROC; NATALIZUMAB; RITUXIMAB; CCR5 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; CYCLOHEXANE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANTIVIRAL THERAPY; B LYMPHOCYTE; BRAIN DAMAGE; CD8+ T LYMPHOCYTE; DISEASE ASSOCIATION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; INFLAMMATION; LETTER; LYMPHOCYTIC INFILTRATION; MICROGLIA; MOLECULARLY TARGETED THERAPY; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; TREATMENT OUTCOME; BIOSYNTHESIS; CONFOCAL MICROSCOPY; HIV INFECTIONS; IMMUNOLOGY; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; METABOLISM;

ANTI-RETROVIRAL AGENTS; CCR5 RECEPTOR ANTAGONISTS; CD8-POSITIVE T-LYMPHOCYTES; CYCLOHEXANES; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MICROSCOPY, CONFOCAL; RECEPTORS, CCR5; TRIAZOLES;

EID: 84925495993     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-015-1383-6     Document Type: Letter

References (7)

1. Giacomini PS, Rozenberg A, Metz I, Araujo D, Arbour N, Bar-Or A (2014) Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome. N Engl J Med 370:486–488
2. Glass WG, Hickey MJ, Hardison JL, Liu MT, Manning JE, Lane TE (2004) Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J Immunol 172:4018–4025
3. + T cells in PML-IRIS during HIV infection. Neurology 81:964–970
4. Martin-Blondel G, Cuzin L, Delobel P, Cuvinciuc V, Dumas H, Alvarez M, Massip P, Marchou B (2009) Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management? Aids 23:2545–2546
5. Martin-Blondel G, Delobel P, Blancher A, Massip P, Marchou B, Liblau RS, Mars LT (2011) Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV. Brain 134:928–946
6. Metz I, Radue EW, Oterino A, Kumpfel T, Wiendl H, Schippling S, Kuhle J, Sahraian MA, Gray F, Jakl V et al (2012) Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathol 123:235–245
7. Trebst C, Staugaitis SM, Tucky B, Wei T, Suzuki K, Aldape KD, Pardo CA, Troncoso J, Lassmann H, Ransohoff RM (2003) Chemokine receptors on infiltrating leucocytes in inflammatory pathologies of the central nervous system (CNS). Neuropathol Appl Neurobiol 29:584–595